Translating Diagnostic Imaging Innovation Program

Working with industry to broaden medical applications of emerging technologies such as magnetic resonance imaging and spectroscopy

Led by former TRI CEO and Director of Research, Professor Carolyn Mountford, a world-leading expert in magnetic resonance technology, this Program involves working with Siemens Healthineers to broaden the medical application of emerging technologies such as magnetic resonance imaging and spectroscopy.

The Program utilises the advanced suite of clinical and diagnostic imaging facilities based at the Princess Alexandra Hospital, including 3T Magnetic Resonance Imaging Positron Emission Tomography (MRI-PET) and Prisma scanners, which allow for precision whole body anatomical and metabolic imaging and image-guided biopsy and radiotherapy. 

• Improving diagnosis of post-traumatic stress disorder and blast trauma in front line defenders - with new findings recently published in Nature Translational Psychiatry
• Improving diagnosis of pain and detecting transition to chronic pain
• Detecting early signs of changes to breast tissue in women at high risk of breast cancer 
• Adolescent brain development 
• A non-invasive method to detect cardiac fibrosis – detecting early changes before progression to heart failure.